HK inno.N Corporation (195940) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HK inno.N Corporation (195940:KRX), powered by AI.

Current Price
₩43,250
P/E Ratio
16.2
Market Cap
1.2T
Sector
Healthcare
What is the HK inno.N Corporation stock price forecast?

HK inno.N Corporation is currently trading at ₩43,250. View real-time AI analysis on Alpha Lenz.

What is HK inno.N Corporation insider trading activity?

View the latest insider trading data for HK inno.N Corporation on Alpha Lenz.

What is HK inno.N Corporation's P/E ratio?

HK inno.N Corporation's P/E ratio is 16.2.

HK inno.N Corporation

KRX · 195940
₩43,250+1,000(+2.37%)Market closedKRX regular session 09:00–15:30 KST
Ask about HK inno.N Corporation's future dividend policy...
Alpha Chat Insight

HK inno.N Corporation trades at a P/E of 16.2 (fair value) with modest ROE of 5.9%.

Ask for details

Company Overview

HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, non-small cell lung cancer, and mesothelioma, and colorectal cancer; and nutrition and intravenous nutrition. It also provides health and beverage products, such as hangover relief, ready to drink, health supplements and health functional foods, as well as active pharmaceutical ingredients. In addition, the company offers beauty products under the bewants, ScalpMed, and KLEDERMA RX brands. It also exports its products to Japan, Southeast Asia, Latin America, Europe, and the Middle East countries. HK inno.N Corporation was founded in 1984 and is headquartered in Cheongju-si, South Korea.

CEO곽달원
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,694

Company Statistics

FY 2025

Profile

₩1,225,267,785,750Market Cap
₩1,063,151,055,390Revenue
28.33MShares Out
1,694Employees

Margins

45.87%Gross
14.83%EBITDA
10.43%Operating
8.59%Pre-Tax
7.12%Net

Valuation

16.19P/E
0.92P/B
1.15EV/Sales
10.50EV/EBITDA
16.19P/FCF

Growth (CAGR)

7.89%Rev 3Yr
12.18%Rev 5Yr
28.28%Op Inc 3Yr
4.96%Op Inc 5Yr
25.68%Net Inc 3Yr
22.10%Net Inc 5Yr

Returns

3.80%ROA
5.87%ROE
5.37%ROIC

Financial Health

₩91,406,200,850Cash & Cash Equivalents
₩677,126,547,950Net Debt
57.85%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

HK inno.N Corporation (ticker: 195940) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,694 employees. Market cap is $1.2T.

The current price is ₩43,250 with a P/E ratio of 16.19x and P/B of 0.92x.

ROE is 5.87% and operating margin is 10.43%. Annual revenue is $1.1T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
HK inno.N Corporation (195940) Stock Forecast 2026 ₩43,250 — Price, Financials & Analyst Targets | Alpha Lenz